Back
Zoetis Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
25
ZTS
Zoetis
Last Price:
149.60
Seasonality Move:
7.36%
Buy
64
BMRN
Biomarin Pharmaceutical
Last Price:
92.06
Seasonality Move:
5.96%
Sell
25
Zoetis (ZTS)
is a Sell
Is Zoetis a Buy, Sell or Hold?
- The current Zoetis [ZTS] share price is $149.56. The Score for ZTS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ZTS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $92.04. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $92.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.45 | Sell |
| Relative Strength Index (14 RSI): | 32.22 | Sell |
| Chaikin Money Flow: | 3487413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (153.12 - 169.84) | Sell |
| Bollinger Bands (100): | (168.42 - 197.44) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 63.34 | Buy |
| Chaikin Money Flow: | 1006040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.97 - 90.61) | Buy |
| Bollinger Bands (100): | (86.65 - 94.75) | Buy |
ZTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 149.93 | Sell |
| 20-day SMA: | 159.4 | Sell |
| 50-day SMA: | 174.23 | Sell |
| 200-day SMA: | 180.13 | Sell |
| 8-day EMA: | 151.34 | Sell |
| 20-day EMA: | 158.38 | Sell |
| 50-day EMA: | 169.45 | Sell |
| 200-day EMA: | 177.16 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.67 | Buy |
| 20-day SMA: | 89.08 | Buy |
| 50-day SMA: | 87.72 | Buy |
| 200-day SMA: | 89.07 | Buy |
| 8-day EMA: | 90.29 | Buy |
| 20-day EMA: | 89.25 | Buy |
| 50-day EMA: | 88.72 | Buy |
| 200-day EMA: | 89.85 | Buy |
Zoetis Earnings Growth & ZTS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.36 per share, and an increase next year of $0.65 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.10 per share, an increase this year of $0.72 per share, and an increase next year of $1.04 per share.
Zoetis Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||